NIH Funding Opportunities (Notices, PA, RFA)

Changing the Status of a PD/PI: Reminder of the NIH Prior Approval Policy
Wait…It’s Not MY Grant?
Occupational Safety and Health Research (R01)
Notice of Intent to Publish a Funding Opportunity Announcement for the Initiative for Maximizing Student Development (IMSD) (T32) Program
Notice of Intent to Publish a Funding Opportunity Announcement for the Undergraduate Research Initiative for Student Enhancement (U-RISE) (T34) Program
Notice of Intent to Publish a Funding Opportunity Announcement for the Graduate Research Initiative for Student Enhancement (G-RISE) (T32) Program
Notice of Intent to Publish a Funding Opportunity Announcement for the Maximizing Access to Research Careers (MARC) (T34) Program
Notice of Early Expiration of PAR-17-053 "Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)"
Register Early & Save for Fall 2018 NIH Regional Seminar in San Francisco, CA
NIH Fiscal Policies in Effect for Fiscal Year 2018
New Podcast: Data Privacy, Access, and Security of the Personal Data NIH Collects on Grantees, Applicants, Investigators, and Trainees
Notice of Change to Application Instructions for RFA-HL-19-009 "Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trail Not Allowed)"
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Clinical Trial Required)
Notice of Pre-Application Webinar and FAQs for RFAs: RFA-OD-18-005, RFA-OD-18-006, RFA-OD-18-007 and RFA-OD-18-008
Notice of Intent to Publish a Funding Opportunity Announcement for Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
Revised: Notice of NIAAA Data-Sharing Policy for Human Subjects Grants Research Funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Notice of NIMHD's Interest in the Causes, Consequences, and Prevention of Violence
Better Defining Growth Medium to Improve Reproducibility of Cell Culture (STTR) (R41/R42 - Clinical Trial Not Allowed)
Better Defining Growth Medium to Improve Reproducibility of Cell Culture (SBIR) (R43/R44 - Clinical Trial Not Allowed)
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)
Request for Information on the Development of the FY 2021-2023 Trans-NIH Plan for HIV-Related Research
Notice of Availability of Administrative Supplements to NIBIB C3i Participants for Advancing Innovation
Notice of updates to PAR-18-656 "NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Notice of Change to Award Budget Table in RFA-HL-19-015 "Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)"
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional)
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Roybal Centers for Translational Research on Aging (P30 - Clinical Trial Required)
Roybal Centers for Translational Research on Dementia Care Provider Support (P30 - Clinical Trial Required)
Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - Clinical Trial Not Allowed)
Rare Genetic Syndromes as a Window into the Genetic Architecture of Mental Disorders (U01 Clinical Trial Not Allowed)
Rare Genetic Syndromes as a Window into the Genetic Architecture of Mental Disorders (Collaborative U01 Clinical Trial Not Allowed)
Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01)
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required)
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional)
Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
If You Run Into SAM Registration Processing Delays, We’ve Got Your Back
Notice of Availability of Administrative Supplements to Support Acquisition and Annotation of Biospecimens from Racial/Ethnically Diverse Cancer Patients for the Development of Models for the Human Cancer Models Initiative (HCMI)
Updates to Registration Process Changes in SAM.gov
Findings of Research Misconduct
Notice of NIBIB Participation in PAR-18-331 "Simulation Modeling and Systems Science to Address Health Disparities (R01 Clinical Trial Not Allowed)"
Research Infrastructure for Centers Conducting Population Dynamics Science FY 2018 (P2C - Clinical Trial Not Allowed)
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed)
Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 - Clinical Trial Not Allowed)
Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 - Clinical Trial Not Allowed)
Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed)
Notice of Change to Application Due Date in RFA-RM-18-006 "Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 - Clinical Trial Not Allowed)"
Notice to Extend the Expiration Date for PAR-15-356 "Major Opportunities for Research in Epidemiology of Alzheimer's Disease and Cognitive Resilience (R01)"
Notice of Availability of Administrative Supplements to NIBIB Grants: Technology Dissemination
Notice to update Application Types Allowed for PAR-18-464: Clinical and Translational Science Award (U54 Clinical Trial Optional)
Notice of Availability of Administrative Supplements to NIBIB Grants: Personalized Imaging Technologies
Notice of Availability of Administrative Supplements to NIBIB Grants: Machine Learning and Deep Learning Solutions
Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)
Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
Minor Use Minor Species Development of Drugs (R01)
Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Clinical Trial Not Allowed)
Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
RCDeCade: 10 Years and Still Counting
Dr. Collins co-authors a JAMA Viewpoint article on the HEAL Initiative Research Plan
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required)
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Centers for the Clinical Trials Network on Pain Research (CTNPR) (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network on Pain Research - Data Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network on Pain Research Clinical Coordinating Center (U24 Clinical Trials not Allowed)
NIAID Policy for T32 and T35 Competing Renewal Application Submissions
Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).
Notice of Correction to Announcement Type for PAR-18-387 "Education and Health: New Frontiers (R01) Clinical Trial Optional"
Request for Information (RFI): Input on Report from Council of Councils on Assessing the Safety of Relocating At-Risk Chimpanzees
Early Registration Ends June 29 for Fall 2018 NIH Regional Seminar in San Francisco, CA
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
Notice of Availability of Administrative Supplements to Support Tool and Resource Development to Address Racial and Ethnic Disparities in Multiple Myeloma
Notice of Frequently Asked Questions for RFA-HL-19-009 "Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trial Not Allowed)"
Phase-out and Termination of NIGMS Participation in the NIH MERIT (R37) Program
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Notice to Extend the Expiration Date for PAR-15-358 "Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (R01)"
NIH Wants You! – Apply to Be Our Next Director of the Center for Scientific Review
Notice of NIMH's Interest in Studies of Neural Circuitry Linked to Computationally-Defined Behaviors of Relevance to Psychiatry in Rodents and Non-Human Primates
Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed)
Notice to Extend the Expiration Date for PAR-15-350 "Emerging Directions for Addressing Health Disparities in Alzheimer's Disease (R03)"
Notice to Extend the Expiration Date for PAR-15-357 "Understanding Alzheimer's Disease in the Context of the Aging Brain (R01)"
Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01)
Notice of Addition of Letter of Intent Due Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Notice of Change to Eligible Organizations in NIAID PAR-18-335 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Notice of Correction to NOT-OD-18-174 "Notice of Intent to Publish a Funding Opportunity Announcement for the Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) Institutional Research Training Program [T32]"
Notice of Pre-Submission Webinars for RFA-TR-18-020: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) and RFA-TR-18-021: Data Management and Coordinating Center (DMCC)
Notice to Extend the Expiration Date for PAR-15-359 "Novel Approaches to Diagnosing Alzheimer's Disease and Predicting Progression (R01)"
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)
Notice of Clarification of NIA intent to fund awards for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"
Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
Notice Regarding New Applications for PAR-15-303: "Occupational Safety and Health Education and Research Centers (42)"
Notice of U.S. Department of Agriculture (USDA) Participation in PAR-17-482 Comparative Genomics Research Program (R01)
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
Request for Information (RFI): Evaluation of the NIH Senator Paul D. Wellstone Muscular Dystrophy Research Centers Program
High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed)
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
Notice to Extend the Expiration Date for PAR-18-027 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)"
Notice to Extend the Expiration Date for PAR-18-179 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)"
Notice of Clarification for Submission of Materials Related to Communications with the FDA for RFA-NS-18-011 "Translational Neural Devices (UG3/UH3 Clinical Trial Required)"
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-012 "Translational Neural Devices (U44 Clinical Trial Required)"
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-021 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)"
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System"
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-022 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)"
Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
NIA AD/ADRD Health Care Systems Research Collaboratory (U54 - Clinical Trial Required)
Request for Administrative Supplements for Basic Research on Opioids to Existing Grant Awards
NIDA Division of Neuroscience and Behavior Will Give High Programmatic Priority to Opioid Related Basic Research
Notice of Change to Application Types Allowed in PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)"
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
Notice to Extend the Expiration Date for PAR-15-349 "Health Disparities and Alzheimer's Disease (R01)"
Notice of Correction to NOT-CA-18-071 "Notice of Intent to Publish a Funding Opportunity Announcement for the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)"
Pre-Application Webinar for RFA-CA-18-015 " NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)"
Pre-Application Webinar for RFA-CA-18-016 " NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)"
Pre-Application Webinar for RFA-CA-18-017 " NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required)"
Notice of Change in Expiration Date and Application and Submission Information for PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)"
Notice of Change in Expiration Date and Application and Submission Information for PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)"
Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIAID Tuberculosis Strategic Plan
Notice of Elimination of the Interview Requirement for Applicants to RFA-RM-18-010 "NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)"
Limited Competition: Human Heredity and Health in Africa Consortium Biorepository (U24 Clinical Trial Not Allowed)
Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed)
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Notice of NHLBI Participation in PA-18-837 "Administrative Supplements to Promote Diversity in Research and Development Small Business-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)"
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)
Notice of Availability of Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan (Admin Supp Clinical Trial Optional)
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)
Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish: Tobacco Cessation Interventions Among People Living with HIV/AIDS (R01 Clinical Trial Optional)
Notice of Intent to Publish: Tobacco Cessation Interventions Among People Living with HIV/AIDS (R21 Clinical Trial Optional)
When to Share or When Not to Share, that is the Privacy Question
Request for Information (RFI): The HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis
Notice of Intent to Publish a Funding Opportunity Announcement for Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR)
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
Notice of Availability of Administrative Supplements for Integrative Data Analysis to extend Research in Cancer Control and Population Sciences (Admin Supp Clinical Trial - Optional)
Notice of a Change to Award Project Period in RFA-DA-19-004,"Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed)"
Rigorous Resources for Rigorous Research
The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed)
Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Notice of Modification to a Page Limitation in PAR-18-266 "Centers of Biomedical Research Excellence (COBRE)(P20)"
Notice of NIMHD Participation in PA-18-343: "Academic Research Enhancement Award (R15 Clinical Trial Required)"
NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Not Allowed)
NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Required)
NIH Synchronizes Institutional Delegations and Now Allows Decimals in Effort Reporting Field in Research Performance Progress Reports (RPPR)
Notice of Intent to Publish a Funding Opportunity Announcement for Reproductive Medicine Clinical Trials Program (R01 Clinical Trial Required)
Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)
NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
Updates for PAR-16-098 "Cooperative Research Agreements Related to World Trade Center Health Program (U01)"
Notice of Modification to a Page Limitation in PAR-18-264 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20)"
Notice of Pre-application Webinar for RFA-CA-18-025 Cooperative Human Tissue Network (CHTN)
The NCATS Trial Innovation Network – A Resource Supporting High Quality and Cost Effective Clinical Trials Available to You
Novel Approaches for Characterizing Exposure and Response to Engineered Nanomaterials (R43 Clinical Trials Not Allowed)
Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support Biennial ELSI Research Conferences (U13)
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)
NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)
New Podcast on NIH Advisory Councils: Understanding What Happens During the Second Round of Peer Review
In part D of the F-RPPR (participants), should we report time worked for the final budget period or time worked for the final budget period + the no cost extension period?
Does the NIH inclusion policy apply to research using existing datasets or other types of existing resources involving human subjects?
What do I do if my proposed study involves both an existing dataset/resource AND recruitment of new participants? How do I address inclusion and complete the forms?
Fall 2018 NIH Regional Seminar Heads to the “City by the Bay” – San Francisco, CA
Expiring Appropriations and What it Means for You – New Video and Podcast
NHLBI Announces Participation in PA-17-444 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)"
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
Notice of Change of Requirements for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
Notice of Change to the Research Areas of Focus for PAR-17-267 "Modeling of Infectious Disease Agent Study Research Projects (R01)"
Request for Information (RFI): Challenges and Opportunities in Understanding Nuclear Organization in Space and Time (4D Nucleome)
Notice of NCI Participation in PA-18-343, "Academic Research Enhancement Award (R15 Clinical Trial Required)"
Notice of Clarification of Eligible Individuals [Program Director(s)/Principal Investigator(s)] for RFA-DK-18-009, Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
Notice Announcing FAQs Page for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)"
Charting Your Small Business’ Course with NIH
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
Notice of Intent to Publish Funding Opportunity Announcement to Promote Screening and Management of Unhealthy Alcohol Use in Primary Care (R18)
Notice of Information for HIV research priorities at the National Heart, Lung, and Blood Institute
Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse Treatment Clinical Trials Network (UG1) Clinical Trial Optional
Notice of NHLBI Participation in PA-18-722 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)"
Notice of Change to Instructions for NOT-OD-18-194 "Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
Notice of Change to Instructions for NOT-OD-18-195 "Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives"
Notice of Change to Due Date and Foreign Institutions Eligibility for Applications to RFA-HD-19-018: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
Notice of NHLBI Participation in PA-18-723 "Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)"
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
Notice of NICHD Participation in PAR-17-471 "Detection of HIV for Self-Testing (R61/R33)"
Notice of NIDCD and NEI Interest in Supporting Research on Usher Syndrome
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
NIAID OMNIBUS BROAD AGENCY ANNOUNCEMENT No. HHS-NIH-NIAID-BAA2018: Soliciting Proposals for Antimicrobial Products, Novel Vaccines and Technologies Against Category A, B, and C Agents, and Universal Influenza Vaccines
Updated Notice of NIH's Interest in Diversity
Notice of Change of Requirements for PAR-18-218, "Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)"
Eliminating senescent cells extends healthy life in mice
Protective liquid enables oral insulin delivery in rats
Technique may improve detection of breast tumors
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp; Clinical Trial Optional)
Notice of Information: Initiative for Collaborative Research Between Investigators in the USA and in Norway
Notice of Information: Change in Letter of Intent Due Dates for PAR-18-747 "Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)"
Notice of Information: Change in Letter of Intent Due Dates for PAR-18-745 "Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)"
Notice of Change of Requirements for PAR-18-219, "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)"
Notice of Clarification to PAR-18-843: Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Data Coordinating Center for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
Notice of Intent to Publish a Funding Opportunity Announcement for Research Site for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
NIH Implementation of the Burden-Reducing Provisions of the 2018 Common Rule
Notice of Clarification for PAR-18-844-Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Notice Regarding New Applications for PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2019-1) Now Available
Notice of Early Application Receipt Date for PAR-18-854, Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
Notice of Correction to Letter of Reference Receipt Date in RFA-DA-18-019 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional)
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional)
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional)
Delayed Enforcement and Short-Term Flexibilities for Some Requirements Affecting Prospective Basic Science Studies Involving Human Participants
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Federal News Radio interviews Dr. Collins on opioid overuse and the NIH HEAL Initiative
Notice of Intent to Publish a Funding Opportunity Announcement for Analytical and Clinical Validation of Biomarkers, Biomarker Signatures, and Endpoints for Pain Indications (R61/R33)
Notice of Clarification of AIDS Receipt Dates for PAR-18-844-Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Notice of Change of Requirements and Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
Notice of Modification to RFA-TR-18-020 Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
NIH/AHRQ Application Submission/Resubmission Policy
Notice of Additional Guidance for Alzheimer's Clinical Trials Consortium (ACTC) Applicants
Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
Soliciting Feedback on the BRAIN Initiative
Notice of Change of Key Dates to RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"
Request for Information (RFI): Strategies for Advancing Sepsis Research Supported by NIGMS
Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator
Notice of Intent to Publish a Funding Opportunity Announcement for NINR Clinical Trial Planning Grant (R34- Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01- Clinical Trial Optional)
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)
In the RPPR, do we need to fill out the Human Subjects and Clinical Trials Information form if we submitted a competing application before January 25, 2018?
NIH Application Resubmission Policy
BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)
BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
How Do You Define a “Study” for the Purposes of Providing Information on the PHS Human Subject and Clinical Trial Form?
Notification that NINDS will Accept Postdoctoral Fellowship Applications (F32; PAR-16-458) in October 2018 from all Potential Applicants who Meet the Eligibility Requirements for the August 2018 Due Date
Notice Announcing Partnership Opportunity for Device-Based Clinical Studies Issued for the Stimulating Peripheral Activity to Relieve Conditions Program
Update on the National Cancer Institute (NCI) "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing "
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed)
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
Testimony on 21st Century Cures Implementation: Updates from FDA and NIH
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed)
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed)
Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed)
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
NIAID T32 and T35 Training Grants Maximum Number of Trainee Slots
Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)
Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2018-2019
Notice of Change in Key Dates in PA-18-842 "Administrative Supplements to Support Cancer Disparity Collaborative Research"
Update on NIHs Next Generation Researchers Initiative (NGRI) Policy on Early Established Investigators (EEIs)
Notice of Change of Application Due Date for RFA-HD-19-018: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Confidentiality in AHRQ-Supported Research
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional)
Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Clinical Trial Not Allowed)
Molecular Atlas of Lung Development Program (LungMAP) Phase 2 Research Centers (U01- Clinical Trial Not Allowed)
Vet-LIRN Network Capacity-Building Projects (U18)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional)
Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Change to Criteria for RFA-HL-19-017 "NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases"
Editing T cell genomes without viruses
How night shifts disrupt metabolism
Early family experience affects later romantic relationships
FDA Standard Core Clinical Outcome Assessments and Endpoints
Genomic Innovator Award (R35 Clinical Trial Optional)
Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Required)
Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed)
Notice of Change in Funds Available and Anticipated Number of Awards for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed)
Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed)
Notice of NIAID Participation in PA-18-393 "Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Clinical Trial Required)"
Notice of Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences
Update - NIH Response to Registration Issues in Sam.gov
Notice of NINR's Participation in NOT-AG-18-020 Notice to Extend the Expiration Date for PAR-18-027 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)"
Notice of NINR's Participation in NOT-AG-18-021 Notice to Extend the Expiration Date for PAR-18-179 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)"
Notice of Clarification of Application Types Allowed for RFA-DK-18-012, Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
Notice of Correction of Peer Review and Council Dates in RFA-DC-19-001 NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
Notice of Pre-Application Webinar for the NIH Common Fund Somatic Cell Genome Editing program
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Notice of Information to the Specific Areas of Research Interest for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)"
New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
RCDeCade: A Case Study to Show NIH Support Trends in an Emerging Scientific Field
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure)
Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)
AHRQ Implementation of the Burden-Reducing Provisions of the 2018 Common Rule
Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)
Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection (U01 Clinical Trial Not Allowed)
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Neuroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)
Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)
Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed)
Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)
OHRP Announces Availability of Three Draft Guidance Documents Related to Revised Common Rule
Trends in Diversity within the NIH-funded Workforce
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for the Reissue of Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
A Look at the Human Subjects System
Looking for the Latest Definition for Terms Relating to Human Subjects and Clinical Trials?
Are Studies Ancillary to Clinical Trials Considered to be Clinical Trials As Well?
You Had Clinical Trial K Application Questions, We Have Answers
Notice of Change in Expiration Date and Application Due Dates for PAR-18-534 "Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Optional)"
Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)
NIGMS Policy on Funding Biomedical Technology Research Resources Beyond Year 15
Notice of Change to PAR-16-412 "NIAID Resource-Related Research Projects (R24)"
Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-16-437 "Support of Competitive Research (SCORE) Research Continuance Award (SC3)"
NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37)
Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-16-439 "Support of Competitive Research (SCORE) Research Enhancement Award (SC1)"
Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-16-438 "Support of Competitive Research (SCORE) Pilot Project Award (SC2)"
Notice of Changes to NICHD Acceptance of Diversity and Re-Entry Supplement Applications
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for NHGRI Center for ELSI Resources and Analysis (CERA): RFA-HG-18-008
Notice of Intent to Publish a Funding Opportunity Announcement for Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center
Notice of NIBIB's Participation in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose"
Notice of the NINDS' Participation in PAR-18-296 and interest in Clinical Trial readiness applications for Frontotemporal Degeneration (FTD) by the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)
Notice of Expiration of PA-18-891, Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
New “All About Grants” Podcast on NIH’s Inclusion Across the Lifespan Policy
Notice of NHLBI Participation in PA-18-592 "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)"
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)
Notice of Correction to Eligibility Information in RFA-AG-19-010 "Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)"
Notice of Expiration of RFA-ES-16-004 "Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24)"
Human Islet Research Network - Consortium on Human Islet Biomimetics (HIRN-CHIB) (UG3/UH3 Clinical Trial Not Allowed)
Notice of Change of Receipt Date for RFA-NS-18-020 "BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
Notice of Change of Receipt Date for RFA-NS-18-019 "BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
Notice of Change of Receipt Date for RFA-EY-18-001 "BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21 Clinical Trial Not Allowed)"
Reminder of Required Letter of Support for PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)"
Notice of Expiration of PAR-18-866 "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)"
Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed)
Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed)
Notice of Expiration of PAR-18-865 "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)"
Notice of Correction to RFA-MH-19-151 "Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed)"
Request for Information (RFI): Registration and Results Reporting Standards for Prospective Basic Science Studies Involving Human Participants
Solicitation of Nominations for the 2019 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
Notice of Change to RFA-AI-18-036 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
Findings of Research Misconduct
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
Notice of Correction to RFA-MH-19-150 "Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional)"
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)(Clinical Trial Optional)
Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed)
Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)
How drugs could repair damage from multiple sclerosis
Impaired brain drainage in aging and Alzheimer’s
Dairy fatty acids not linked to death in older adults
Statement on modernizing human gene therapy oversight
We Want Your Feedback About Results Reporting for Basic Science Studies Involving Human Participants
Researchers find potential new gene therapy for blinding disease
Statement on the retirement of Dr. Patricia Grady
NIH officials: closing treatment gaps critical to ending the U.S. HIV epidemic
Researchers identify key brain circuits for reward-seeking and avoidance behavior
Rapid development in Central Africa increases the risk of infectious disease outbreaks
Testimony on Prioritizing Cures: Science and Stewardship at the National Institutes of Health
Statement on Protecting the Integrity of U.S. Biomedical Research
Assistive surgical devices shine in DEBUT biomedical engineering design competition
NIH Request for Public Comment on the Draft Protocol Template for Behavioral and Social Sciences Clinical Trials
EXP2 protein helps deadliest malaria parasite obtain nutrients during infection
Researchers unearth secret tunnels between the skull and the brain
Responsive parenting affects childhood weight
Exploring induced labor for full-term pregnancy
Learning about fatal opioid overdoses changes prescribing behavior
Notice of Increases to the Simplified Acquisition and Micro-purchase Thresholds by the Office of Management and Budget
HIV/AIDS research yields dividends across medical fields
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)
Notice of Corrections to RFA-MD-18-011, "Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed)"
NHLBI Interest in Administrative Supplements to Enhance HIV-related Heart, Lung, Blood, and Sleep Research
Notice of Updated Application Forms Package for Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
Notice of Updated Application Forms Package for Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed).
New “All About Grants” Podcast on Valid/Stratified Analyses
Notice of Availability of Administrative Supplements to NCCIH Grants to Address Opioid Use Disorder and/or Pain
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-18-643 "NHLBI Clinical Ancillary Studies (R01- Clinical Trial Optional)"
Notice to Extend PAR-18-267 "Pilot Services Research Grants Not Involving Interventions (R34 Clinical Trial Optional)"
Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)
Protecting Human Research Participants (PHRP) Online Tutorial No Longer Available as of September 26, 2018
More patients survive sudden cardiac arrest with new EMS technique
NIH research program to explore the transition from acute to chronic pain
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed)
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
Event registration opens today for National Drug & Alcohol Facts Week
NIH names Dr. Helene Langevin director of the National Center for Complementary and Integrative Health
Study finds multiple sclerosis drug slows brain shrinkage
Notice of NCI Participation in RFA-ES-18-012, Human Health Exposure Analysis Resource: UnTargeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)
Notice of Change to NIAMS Acceptance of Diversity and Re-Entry Supplement Applications
Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24 Clinical Trial Not Allowed)
OHRP Exploratory Workshop: “Meeting New Challenges in Informed Consent in Clinical Research”
Notice of Change in Research Objectives for PAS-16-033, Stimulating Hematology Investigation: New Endeavors (SHINE) (R01)
Correction to the Application Forms Package issued for RFA-AI-18-036 Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
Human Health Exposure Analysis Resource: Data Repository, Analysis and Science Center (U2C Clinical Trial Not Allowed)
Human Health Exposure Analysis Resource: Environmental Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)
Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)
Human Health Exposure Analysis Resource: UnTargeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)
Human Health Exposure Analysis Resource: Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish Funding Opportunity Announcements for the NIA Demography and Economics of Aging Centers Program
Notice of Information: Re-instituting Payments for the NIA Aging Cell Repository/NIA Cell Bank Collections
Notice of NCI Participation in RFA-ES-18-011, Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)
Study provides an early recipe for rewiring spinal cords
Notice of Change to Application Review Information in PAR-18-802, "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)"
Notice of Change to Application Review Information in PAR-18-801 "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)"
Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)
Notice of Intent to Publish Funding Opportunity Announcements for the Collaborative Pediatric Critical Care Research Network (CPCCRN) (R01 Clinical Trial Optional)
Notice of Extension of the Expiration Date for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-703 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33-Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-704 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33-Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-705 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33-Clinical Trial Required)
Notice of Extension of the Expiration Date for RFA-MH-18-706 "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)"
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for NIH and USDA Prospective Applicants to PAR-17-482 Comparative Genomics Research Program (R01-Clinical Trial Not Allowed)"
Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed)
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required)
Novel intervention halves rate of death among people living with HIV who inject drugs
Genetics and pollution drive severity of asthma symptoms
Notice of Pre-Application Webinar for the NIH Common Fund Acute to Chronic Pain Signatures Program
Additional Awards Eligible for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid Innovation Network Advanced Analytics and Methodology Center
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid Innovation Network Coordination and Translation Center
Notice of Changes to NICHD Acceptance of Diversity and Re-Entry Supplement Applications
Notice of Correction of PA-18-871, "BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 Clinical Trial Not Allowed) "
Notice of Added Research Goals for RFA-DA-19-005 "Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-707 "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-701 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (R01 Clinical Trial Required)"
Notice of Extension of the Expiration Date for RFA-MH-18-700 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (Collaborative R01 Clinical Trial Required)"
Request for Information (RFI): Soliciting Input for future research at the National Heart, Lung, and Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in patients with Hemophilia A
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
NIH study broadens understanding of High Impact Chronic Pain in the U.S.
NIH grants will spur innovation in under-resourced states
Stress wracks worm nerves, leaving lasting memories
Daily use of marijuana among non-college young adults at all-time high
Clinical trial testing topical cream plus influenza vaccine in progress
Time is Limited to Save on the 2018 NIH Regional Seminar on Program Funding & Grants Administration in San Francisco – Act Now!
Clarification: Fixed Amount Award Definition and Implementation for Clinical Trials
Longer daily fasting times improve health and longevity in mice
NIH taps Bruce J. Tromberg, Ph.D., to lead the National Institute of Biomedical Imaging and Bioengineering
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R21-Clinical Trials Not Allowed)
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
NIMHD Loan Repayment Program Technical Assistance Webinar
Notice of Termination of PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)"
Notice of Termination of PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)"
Notice of Extension of Expiration Date for PAR-15-344 "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)
Request for Information (RFI): Current Clinical Management and Assessment Practices in Lung Transplantation
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid Innovation Network Clinical Research Sites
Notice of Key Date Changes for RFA-MD-18-010 " Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)"
Pre-Solicitation Notice: Patient Safety Monitoring in International Laboratories (SMILE)
Request for Proposals (RFP) Notice: Quantification of Drugs of Abuse and Related Substances in Biological Specimens
Protecting Human Research Participants (PHRP) Online Tutorial No Longer Available as of September 26, 2018
U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
Funding Longevity by Gender Among NIH-Supported Investigators
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed
Findings of Research Misconduct
RPPRs: Who Can Do What?
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
Refresh Your Knowledge of Roles in eRA Commons
Early stage clinical trial of antimalarial drug begins
Regenerating light-sensing eye cells in mice
Predicting response to immunotherapy
Device improves survival after sudden cardiac arrest
Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50)
Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Exploratory Grant for Morris K. Udall Center without Walls for Parkinsons Disease Research (P20)
Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)
Development of New Antibacterial Drugs Active Against Multi-Drug Resistant Bacteria
Notice of Correction to application forms package for PA-17-326 "Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement)"
Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
Notice of Participation of ECHO in RFA-ES-18-012 "Human Health Exposure Analysis Resource: Untargeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)"
Notice of Participation of ECHO in RFA-ES-18-011 "Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)"
Notice of Participation of ECHO in RFA-ES-18-013 "Human Health Exposure Analysis Resource: Environmental Monitoring Laboratories (U2C Clinical Trial Not Allowed)"
Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research on Drug Abuse (R21)"
Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research on Drug Abuse (R01)"
Notice of Early Expiration of PAR-17-048 "Phylodynamic Tracking of HIV Transmission (R01)"
High blood sugar during pregnancy ups risk of mother’s type 2 diabetes, child’s obesity
NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp Clinical Trial Optional)
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"
NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (R25)
Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18)
Reminder: NIH Natural Disaster Policy - Hurricane Florence
Notice of Intent to Publish a Funding Opportunity Announcement for Post-Stroke VCID in the United States Including in Health Disparities Populations (U19 Clinical Trial Not Allowed)
Neurons absorb and release water when firing, NIH study suggests
NIH launches initiative to accelerate genetic therapies to cure sickle cell disease
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
NIH and AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications
NIH and AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Fellowship Award Applications
NIH and AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Career Development Award Applications
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed)
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed)
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed)
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed)
Notice of Pre-Application Technical Assistance Webinar for RFA-MD-18-011, Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed)
Notice of NICHD's Participation in PA-18-817 "Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)"
Notice of Intent to Publish a Funding Opportunity Announcement to Support Institutional Translational Research Training Programs (T32)
Notice of Intent to Publish a Funding Opportunity Announcement to Support NINDS-Specific Institutional Research Training Programs (T32)
Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FY) 2020-2024
Notice of Change in Expiration Date for PAR-18-853 "Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)"
Notice of Change to Receipt Date on Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed) (PAR-18-909)
Daily low-dose aspirin found to have no effect on healthy life span in older people
NIH Policies to Address Sexual and Gender Harassment in NIH-supported Extramural Research
Notice of Clarification: Research Strategy page limit for PA-18-794, AHRQ Small Research Grant Program (R03)
NIH and Children’s National partner to advance pediatric clinical research
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
Gene variations linked to severity of Zika-related birth defects, small NIH study suggests
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
Changing the culture of science to end sexual harassment
Experimental nasal influenza vaccine tested in kids, teens

NIH Funding Opportunities (Notices, PA, RFA)

Quick Links

Request Services

Contact